论文部分内容阅读
对于有已知心血管疾病或有心血管疾病风险患者,COX-2抑制剂应作为最后选择药物。美国心脏协会(AHA)最近发表的一个科学报告“非甾体抗炎药物的
For patients with known cardiovascular disease or cardiovascular risk, COX-2 inhibitors should be used as the last choice drug. A recent scientific report by the American Heart Association (AHA) entitled "Non-steroidal anti-inflammatory drugs